Cited 0 time in
DOT1L: a new therapeutic target for aggressive breast cancer
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lee, Jeong-Yeon | - |
| dc.contributor.author | Kong, Gu | - |
| dc.date.accessioned | 2022-07-15T20:54:41Z | - |
| dc.date.available | 2022-07-15T20:54:41Z | - |
| dc.date.issued | 2015-10 | - |
| dc.identifier.issn | 1949-2553 | - |
| dc.identifier.issn | 1949-2553 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/156284 | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | Impact Journals | - |
| dc.title | DOT1L: a new therapeutic target for aggressive breast cancer | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.18632/oncotarget.5860 | - |
| dc.identifier.scopusid | 2-s2.0-84945538337 | - |
| dc.identifier.wosid | 000363185200016 | - |
| dc.identifier.bibliographicCitation | Oncotarget, v.6, no.31, pp 30451 - 30452 | - |
| dc.citation.title | Oncotarget | - |
| dc.citation.volume | 6 | - |
| dc.citation.number | 31 | - |
| dc.citation.startPage | 30451 | - |
| dc.citation.endPage | 30452 | - |
| dc.type.docType | Editorial Material | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Oncology | - |
| dc.relation.journalResearchArea | Cell Biology | - |
| dc.relation.journalWebOfScienceCategory | Oncology | - |
| dc.relation.journalWebOfScienceCategory | Cell Biology | - |
| dc.subject.keywordPlus | acyltransferase | - |
| dc.subject.keywordPlus | disruptor of telomeric silencing 1 like protein | - |
| dc.subject.keywordPlus | disruptor of telomeric silencing 1 like protein inhibitor | - |
| dc.subject.keywordPlus | histone H3 | - |
| dc.subject.keywordPlus | histone lysine methyltransferase inhibitor | - |
| dc.subject.keywordPlus | histone methyltransferase | - |
| dc.subject.keywordPlus | lysine | - |
| dc.subject.keywordPlus | Myc protein | - |
| dc.subject.keywordPlus | pinometostat | - |
| dc.subject.keywordPlus | transcription factor | - |
| dc.subject.keywordPlus | transcription factor Snail | - |
| dc.subject.keywordPlus | transcription factor ZEB1 | - |
| dc.subject.keywordPlus | transcription factor ZEB2 | - |
| dc.subject.keywordPlus | unclassified drug | - |
| dc.subject.keywordPlus | antineoplastic agent | - |
| dc.subject.keywordPlus | benzimidazole derivative | - |
| dc.subject.keywordPlus | DOT1L protein, human | - |
| dc.subject.keywordPlus | EPZ-5676 | - |
| dc.subject.keywordPlus | histone | - |
| dc.subject.keywordPlus | methyltransferase | - |
| dc.subject.keywordAuthor | Chromosome Section | - |
| dc.subject.keywordAuthor | DOT1L | - |
| dc.subject.keywordAuthor | histone methylation | - |
| dc.subject.keywordAuthor | EMT | - |
| dc.subject.keywordAuthor | breast cancer | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
